Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2000
[Treatment and prognosis of children with relapsed non-Hodgkin's lymphoma--a report from CCLSG-NHL 890 Study. Children's Cancer and Leukemia Study Group (CCLSG)]M Tsurusawa, N Katano, K Asami, et al.
British Journal of Cancer|April 16, 2002
Experience with International Neuroblastoma Staging System and Pathology ClassificationH Ikeda, T Iehara, Y Tsuchida, et al.
Bone Marrow Transplantation|June 19, 1998
Peripheral blood stem cell autografts for the treatment of children over 1 year old with stage IV neuroblastoma: a long-term follow-upH Eguchi, Y Takaue, Y Kawano, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1997
[Myelogenous leukemia in children. ANLL9205 study by Children's Cancer and Leukemia Study Group (CCLSG)]J Mimaya, Y Horikoshi, H Shimizu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 7, 2013
A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamicsA Shirahata, K Fukutake, J Takamatsu, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 10, 1998
[Treatment results of intermittent and cyclic regimen with ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group]T Hirota, T Fujimoto, N Katano, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 3, 2016
A phase III clinical trial of a mixture agent of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitorsY Shinkoda, A Shirahata, K Fukutake, et al.
Leukemia|February 12, 1999
Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia. The Children's Cancer and Leukemia Study Group, JapanT Iwai, S Yokota, M Nakao, et al.
Medical and Pediatric Oncology|April 2, 1999
Improvement in CNS protective treatment in non-high-risk childhood acute lymphoblastic leukemia: report from the Japanese Children's Cancer and Leukemia Study GroupM Tsurusawa, N Katano, Y Yamamoto, et al.
Pageof 6